Mylan’s board nominees were elected in full at the pharmaceutical company’s annual meeting Thursday despite pressure from a group of institutional investors unhappy over high executive pay.
from WSJ.com: US Business http://ift.tt/2t0hO4G
via IFTTT
No comments:
Post a Comment